New Treatment Breakthroughs in the
Management of HIV: Expert Strategies for Optimized Clinical and
A continuing medical education
activity provided by NAMCP and AAMCN
This activity is an archive from the live session from the 2020
Spring Managed Care Forum. If you participated in the live session,
you are not eligible for continuing education credits from this
This activity is valid from July 1, 2020 to July 1, 2021
Instructions for CME/NCPD: Complete the pre-test, listen to the
audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name
and email address on the pre-test, evaluation and post-test. If you
close your internet browser without completing the post test, you
will have ONE more opportunity to complete. A score of 70% must be
achieved on the post test to receive continuing education credits.
If you do not pass the post test after two attempts, you will not be
eligible to try again. Once you complete the evaluation form and
score 70% or higher on your post test, you will automatically be
given your certificate.
To print or save your certificate, you will need to click on the
“download” button and either print or save.
This activity is intended for healthcare professionals practicing in
managed care environments.
This activity is supported by
an educational grant from
The human immunodeficiency virus (HIV) is a lentivirus that causes
HIV infection and over time acquired immunodeficiency syndrome
(AIDS). AIDS is a condition in humans in which progressive failure
of the immune system allows life-threatening opportunistic
infections and cancers to thrive. HIV infects vital cells in the
human immune system such as helper T cells, macrophages, and
dendritic cells. The CDC estimates that 1,218,400 persons in the
United States aged 13 years and older are living with HIV infection.
Fortunately for patients with HIV, several new therapies have become
available over the past few years, and more are set to become
available soon. Treatment regimens vary and carry important
differences between therapeutic options that are clinically relevant
to healthcare professionals. HIV treatment focuses on controlling
the disease and living longer, healthier lives. Antiretroviral
therapy (ART) is the use of HIV medicines to treat HIV infection.
ART has evolved considerably over the past three decades. With many
antiretroviral drugs, combinations, and classes available, health
care providers have multiple choices regarding ART. One of the
biggest challenges for clinicians is individualizing the care of
HIV-positive patients and understanding when certain ART therapies
and strategies are appropriate, and when they are not. Numerous
studies have shown that ART must be tailored to the individual
patient and his or her abilities and diverse needs.
Upon completion of this
activity, participants will be able to:
Analyze the clinical and economic
impact of an HIV infection on a patient
Differentiate new and emerging
antiretroviral therapies (ART) based on the latest evidence for
their efficacy, safety, and adherence potential
Evaluate patient-specific factors,
including age, comorbidities, concomitant medications, and
adherence challenges, in making decisions about emerging HIV
Explore recent clinical data on
emerging HIV-treatment paradigms, including novel medication
combinations and drug-delivery or dosing methods to simplify ART
Apply current guidelines and
evidence to decisions on initiating ART or switching ART in the
setting of virologic suppression or failure
Assess the managed care
considerations of emerging therapies, including combination
options, by exploring where these agents fit in the HIV
||David Alain Wohl, MD
Professor, Division of Infectious Diseases
The University of North Carolina at Chapel Hill
Site Leader, UNC AIDS Clinical Trials Unit at Chapel
serves on an advisory board for Gilead, Janssen, Merck,
and ViiV. He has received grant/research support from
Gilead, Merck, and ViiV. His presentation has been peer
reviewed for any bias.
MD has no real or perceived financial relationships to
Jeremy Williams has no real or perceived financial
relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no real or perceived
financial relationships to disclose.
NAMCP and/or the presenter
has copyright or has received permissions for use of
materials provided in this activity.
Accreditation & Designation
This activity has been planned and implemented in accordance with
the accreditation requirements and policies of the Accreditation
Council for Continuing Medical Education (ACCME) through the joint
providership of the National Association of Managed Care Physicians
(NAMCP) and American Association of Managed Care Nurses (AAMCN). The
National Association of Managed Care Physicians is accredited by the
ACCME to provide continuing medical education for physicians.
NAMCP designates this enduring material for a maximum of 1 AMA
PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their
participation in the activity.
The American Association of Managed Care Nurses is accredited as a
provider of nursing continuing professional development by the
American Nurses Credentialing Center's Commission on Accreditation.
Nurses who complete this activity and achieve a passing score will
receive 1 hour in nursing continuing professional development.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
This activity is supported by
an educational grant from
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
Click Here To Continue